The report highlights Biogen's commitment to corporate responsibility and its achievements in 2022, including a 3% reduction in scope 1 and 2 emissions from a 2019 baseline year, expansion of its electric vehicle program to 15 countries, and continued support for its global Community Lab program which has now reached over 62,000 students in 30 countries. The report also highlights Biogen's work to advance health equity, including its commitment to diverse clinical trial recruitment, the development of new treatments for Alzheimer's disease and amyotrophic lateral sclerosis, and efforts to expand access to its therapies for people living with spinal muscular atrophy in 69 countries, including 19 low- and middle-income countries.
Issuing Company Biogen Inc.
Report Type Sustainability Report
Report Language EN
Report Filesize 3.59 MB
No. of Pages 75 pages
Reporting periodJanuary 1, 2022-December 31, 2022
Report EditionUnknown
Assurance Provider ERM Certification and Verification Services, Inc. (ERM CVS)
Reporting Standards GRI; SASB; TCFD
Materiality Assessmenttrue